A Phase III Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
Sponsors and Collaborators
Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd
Next post in Hyperphosphatemia Clinical Trials
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
Want to read more?
Please login or register first to view this content.